puromycin aminonucleoside has been researched along with topiroxostat in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujigaki, Y; Hosoyamada, M; Kawamorita, Y; Kumagai, T; Nakagawa, T; Shibata, S; Shiraishi, T; Tamura, Y; Uchida, S | 1 |
1 other study(ies) available for puromycin aminonucleoside and topiroxostat
| Article | Year |
|---|---|
Renoprotective effect of topiroxostat via antioxidant activity in puromycin aminonucleoside nephrosis rats.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Animals; Antioxidants; Cell Line; Deoxyguanosine; Enzyme Inhibitors; Kidney; Male; Mice; NADPH Oxidase 4; Nephrosis; Nitriles; Oxidative Stress; Podocytes; Puromycin Aminonucleoside; Pyridines; Rats; Rats, Sprague-Dawley; Uric Acid | 2017 |